Background-Although ventricular tachycardia (VT) ablation is a widely used therapy for patients with VT, the ideal end points for this procedure are not well defined. We performed a meta-analysis of the published literature to assess the predictive value of noninducibility of postinfarction VT for long-term outcomes after VT ablation. Methods and Results-We performed a systematic review of MEDLINE (1950MEDLINE ( -2013, EMBASE (1988EMBASE ( -2013, the Cochrane Controlled Trials Register (Fourth Quarter, 2012), and reports presented at scientific meetings (1994)(1995)(1996)(1997)(1998)(1999)(2000)(2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011)(2012)(2013). Randomized controlled trials, case-control, and cohort studies of VT ablation were included. Outcomes reported in eligible studies were freedom from VT/ventricular fibrillation and all-cause mortality. Of the 3895 studies evaluated, we identified 8 cohort studies enrolling 928 patients for the meta-analysis. Noninducibility after VT ablation was associated with a significant increase in arrhythmia-free survival compared with partial success (odds ratio, 0.49; 95% confidence interval, 0.29-0.84; P=0.009) or failed ablation procedure (odds ratio, 0.10; 95% confidence interval, 0.06-0.18; P<0.001). There was also a significant reduction in all-cause mortality if patients were noninducible after VT ablation compared with patients with partial success (odds ratio, 0.59; 95% confidence interval, 0.36-0.98; P=0.04) or failed ablation (odds ratio, 0.32; 95% confidence interval, 0.10-0.99; P=0.049). Conclusions-Noninducibility of VT after VT ablation is associated with improved arrhythmia-free survival and all-cause mortality. (Circ Arrhythm Electrophysiol. 2014;7:677-683.)
S everal studies have demonstrated the efficacy of radiofrequency catheter ablation as adjunctive therapy in selected patients with recurrent, drug-resistant ventricular tachycardia (VT). 1, 2 Despite major advances in the field, this therapy remains technically challenging and time-consuming. 3, 4 Different ablation strategies have been proposed, and their outcomes have been different across clinical trials. [5] [6] [7] [8] Several studies have demonstrated that patients in whom VT cannot be induced at the conclusion of an ablation have a favorable outcome. 9, 10 However, these studies have been limited because of the small number of patients, heterogeneous population, and lack of long-term follow-up. Therefore, the ideal end point of VT ablation in patients with prior infarction is unclear. To answer this important clinical question, we evaluated the outcomes of patients with prior myocardial infarction who were noninducible after VT ablation compared with those who remained inducible at the end of the procedure through a meta-analysis of studies published in the literature.
Web-based search engine OVID with explode option for each subject term and the option AND for combining keywords. The MEDLINE was searched from January 1950 to May 2013. The MeSH terms included VT and ablation. We also used a previously developed MEDLINE search strategy to retrieve the strongest scientific studies of treatment by conducting a sensitive search. 11 The EMBASE database was searched from January 1988 to 2013 with keywords including VT and catheter ablation. The Cochrane Controlled Trials Register was searched with a similar approach. All searches were performed in May 2013. We conducted additional searches using 11 author names frequently cited in narrative reviews of VT ablation, as well as modified versions of the Cochrane Optimal Search Strategy. 12 The bibliographies of 10 most recent narrative review articles were also hand-searched. To reduce bias, we restricted our searches to articles reported in English language. 13 Because the meta-analysis was an analysis of prior published studies, an institutional review board approval is not applicable.
Study Selection
Randomized controlled trials, case-control, or cohort studies evaluating ablation for treatment of VT were eligible. Case-control and cohort studies were defined according to the STROBE (STrengthening the Reporting of OBservational studies in Epidemiology) statement. The study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.
Studies were included if the outcome was reported depending on inducibility of VT after completion of the ablation procedure. The outcomes of interest were recurrence of VT/ventricular fibrillation (VF) and all-cause mortality. Authors of relevant studies were contacted to obtain these data if not reported in the original article. Additional information from 4 studies was provided by the authors and included in the article. We included only studies with a postablation programmed ventricular stimulation protocol. A limitation of programmed stimulation is the lack of a universally agreed protocol for VT induction. 14, 15 This analysis, therefore, was limited to studies using a generally accepted stimulation protocol with ≥2 basic drive cycle lengths with ≤3 extrastimuli at 2 ventricular sites. 4 The length and adequacy of follow-up in all the included trials were thought to be sufficient to allow the outcomes of interest to occur within the follow-up period.
Data Abstraction
Two independent reviewers (H.G. and S.F.) evaluated the studies for inclusion into the meta-analysis. A third blinded reviewer (F.B.) resolved disagreements between reviewers. Abstracted data included eligibility criteria, baseline characteristics, duration of follow-up, cause of heart failure, procedural complications, and number of patients in the trial.
Definitions
Complete success was defined as elimination of all inducible VTs at the conclusion of the procedure. Partial success was defined as elimination of all clinical VTs with ≥1 nonclinical VT inducible at the end of the procedure. The procedure was labeled as unsuccessful if any clinical VT still was inducible at the end of the procedure.
Quality Assessment
We used the Newcastle-Ottawa Scale to describe the quality of the studies included in the meta-analysis. The items assessed for cohort studies were as follows: (1) representativeness of the exposed cohort, (2) selection of the nonexposed cohort, (3) ascertainment of exposure, (4) outcome of interest not present at the onset of the study, (5) comparability of cohorts on the basis of the design or the analysis, (6) assessment of outcome, (7) length of follow-up long enough for outcomes to occur, and (8) adequacy of follow up of cohorts. One or 2 stars were assigned and are displayed in Table I in the Data Supplement summarizing risk of bias.
We used the Grades of Recommendations, Assessment, Development, and Evaluation system to evaluate the quality of the evidence for outcomes reported in this review. Because only observational studies were available, the body of evidence was assigned according to the Grades of Recommendations, Assessment, Development, and Evaluation system as low quality in the first place. 16 For most outcomes, the quality of evidence was further downgraded to very low quality. The summary of findings and evidence profile were created using the Grades of Recommendations, Assessment, Development, and Evaluation software.
Statistical Analysis
Odds ratio (OR) was chosen as the principal measure of effect. The ORs from each included study were pooled using fixed-and random-effects models that used weighting based on inverse variance calculated according to DerSimonian and Laird. 17 The Q test and I 2 index were used to check for quantitative heterogeneity, 18 with P<0.05 deemed statistically significant. Where no significant statistical heterogeneity was identified, the fixed-effects estimate was used preferentially as the summary measure. Sensitivity analyses were performed to assess the contribution of each study to the pooled estimate by excluding individual trials one at a time and recalculating the pooled OR estimates for the remaining studies. Publication bias was assessed graphically using a funnel plot and mathematically using an adjusted rank correlation test, according to the method of Begg and Mazumdar. 19 Sensitivity analyses were performed to assess the importance of different statistical models. There were no differences in the general direction of outcomes when using the fixed-and random-effects models. All statistical analyses were performed with Comprehensive Meta-Analysis 2.0.
Results

Qualitative Analysis
All the trials included in this analysis were observational cohort studies. Baseline characteristics of the patients enrolled in these trials, types of cardiomyopathy, and follow-up and ablation strategies are summarized in the Table. There were sufficient similarities in these trials warranting their inclusion in this analysis. We have summarized the qualitative differences between groups using the Newcastle-Ottawa Scale in Table I 
Quantitative Analysis
Of 3895 studies evaluated, we identified 8 cohort studies enrolling 928 patients for the meta-analysis ( Figure IV in the Data Supplement). [20] [21] [22] [23] [24] [25] [26] [27] Additional information from 4 articles was provided by the authors and included in the final analysis. 20, 23, 26, 27 The Q 2 test score was 10.01, and the I 2 index was 50.08 indicating moderate heterogeneity (P=0.07). There was no evidence of significant publication bias according to Begg and Mazumdar rank correlation test (τ=−0.13; P=0.71). We performed several sensitivity analyses to assess the effect of each study on the pooled effect estimate. Exclusion of no single trial significantly altered the overall result of our analysis.
Efficacy of VT ablation
Noninducibility of VT was achieved in the majority of the patients (event rate, 0.59; 95% confidence interval [CI], 0.49-0.67). Partial success was achieved in a higher number of patients (event rate, 0.27; 95% CI, 0.20-0.36) compared with failed ablation (event rate, 0.10; 95% CI, 0.06-0.17).
Noninducibility and Recurrence of VT/VF
There were a significant number of patients who had recurrence of VT after the ablation procedure, despite being noninducible at the conclusion of the procedure (range, 11%-37%). However a larger number of patients who had a failed ablation had recurrence of VT (range, 76%-100%). There were also a significant number of patients with partial success who had recurrence of VT after ablation (range, 27%-61%). Patients who were rendered noninducible at the conclusion of the index VT ablation procedure were less likely to have recurrence of VT/VF during follow-up compared with patients with a partially successful (OR, 0.49; 95% CI, 0.29-0.84; P=0.009; Figure 1 ) or a failed ablation procedure (OR, 0.10; 95% CI, 0.06-0.18; P<0.001; Figure 2 ). Patients with partial success were less likely to have recurrence of VT/VF compared with those with failed ablation (OR, 0.24; 95% CI, 0.13-0.45; P<0.001; Figure 3 ). , and effect for each study (squares) are displayed; overall effect and effect for each study represent the width of the CI. Two studies 21 did not report VT/ventricular fibrillation (VF) events, and 1 study 25 reported VT/VF events in every patient; therefore, they were not included in the overall analysis.
Patients who were noninducible at the end of the ablation procedure had a lower risk of mortality compared with those with a partially successful procedure (OR, 0.59; 95% CI, 0.36-0.98; P=0.04; Figure 4 ) or failed ablation (OR, 0.32; 95% CI, 0.10-0.99; P=0.049; Figure 5 ). There was no difference in mortality in patients in whom only the clinical VT could be eliminated compared with the patient group in whom the ablation failed (OR, 0.37; 95% CI, 0.11-1.22; P=0.10; Figure 6 ).
Discussion
Main Findings
This meta-analysis demonstrates that lack of inducibility of any VT after ablation of postinfarction VT is associated with longer longevity and lower VT/VF recurrence and, therefore, is a reasonable end point for VT ablation.
Lack of VT Inducibility as an End point for VT Ablation
The traditional end point of VT ablation has been noninducibility of VT using programmed ventricular stimulation. 4 The use of this end point in determining the success of VT ablation has been called into question because of its many limitations. 28 Several studies have attempted to clarify the value of programmed stimulation to predict outcome after an ablation procedure, but they have been limited by a small number of patients with short-term follow-up. A randomized clinical trial would be the most appropriate way to answer this question.
However, in the absence such a trial, a meta-analysis is an important tool in helping clinicians determine the value of noninducibility on the outcomes of VT ablation procedures. This meta-analysis demonstrated that noninducibility of VT was associated with a significant reduction in both mortality and recurrence of VT/VF events. It is possible, though, that the patients who remain noninducible after VT ablation may represent a healthier population with a more favorable outcome. Therefore, lack of inducibility may represent a healthier substrate rather than an ideal outcome after VT ablation.
Limitations of Programmed Stimulation as an End Point for VT Ablation
There are several limitations when performing programmed stimulation after VT ablation procedures. The lack of inducibility of VTs up-front and the potential suppression of VTs with antiarrhythmics such as amiodarone make it difficult to be certain that all of the VTs in a given patient have been targeted and eliminated during the ablation procedure. Not all VTs are reproducibly inducible, and the lack of reproducibility of VT induction may limit the predictive value of noninducibility at the end of the ablation procedure. Furthermore, programmed stimulation at the conclusion of a long ablation procedure may not be safe in an unstable patient and, therefore, may need to be deferred. The substrate responsible for initiation and maintenance of VT in patients with ischemic heart disease is prone to changes over time. A changing substrate may curtail the prediction of future events based on programmed stimulation at one point in time. Despite these limitations, the predictive value of programmed stimulation cannot be ignored, and to assure the best possible Figure 3 . Partial success vs failed ablation and ventricular tachycardia (VT) recurrence. One study 26 did not report VT/ventricular fibrillation (VF) events, and 1 study 25 reported VT/VF events in every patient; therefore, they were not included in the overall analysis. CI indicates confidence interval. outcome of a VT ablation procedure, programmed stimulation should strongly be considered at the conclusion of the ablation procedure. A recent report in which ablation of the entire scar was performed supports this consideration. A strategy targeting and ablating the entire low-voltage area demonstrated a significantly improved outcome compared with patients in whom arrhythmias were specifically targeted, provided that the patients were rendered completely noninducible. 29 The former study confirms the value of programmed stimulation as an end point when different ablation strategies are compared.
In patients in whom no VT can be induced at baseline, a different ablation strategy needs to be pursued. The predictive value of abolition of late potentials as a procedural end point has been evaluated and found to be beneficial especially in patients without inducible VTs at baseline. 30
Ablation of the Clinical VT and Outcomes
Our analysis demonstrated only a trend toward reduced mortality in patients in whom VT remained inducible after ablation if at least the clinical VTs could be eliminated. There was, however, a significant reduction of VT recurrence if this end point was achieved. This information is important because common practice considers targeting the clinical VT as an acceptable strategy, 4 and based on this analysis complete elimination of VT was associated with significantly lower mortality and VT recurrence compared with partial success and may, therefore, be considered a preferred end point when feasible.
A smaller study including both ischemic and nonischemic patients also demonstrated similar results. 10 However, inducibility of multiple VTs before the procedure and failure to eliminate all VTs may just identify a sicker patient population with larger scar burden. Therefore, failure to eliminate VTs may identify a more diseased patient population with a worse prognosis and higher likelihood of future VT/VF recurrence. However, failure to eliminate VT after ablation in high-risk patients has been associated with an increase in cardiac mortality compared with high-risk patients in whom VT could be eliminated. 27 Therefore, it is possible that effective ablation alone confers a more favorable impact on outcomes, particularly in high-risk patients.
Search for an Optimal Ablation End Point
Despite the predictive value of programmed stimulation on outcomes, patients still have VT recurrences even if they are completely noninducible at the end of the ablation procedure. The use of noninvasive programmed stimulation a few days after VT ablation has been described to help improve assessment of outcomes after VT ablation. 5, 31 Edema formation may prohibit VT inducibility immediately after ablation as opposed to inducibility several days later after some of the edema has resolved. This strategy may not affect intraprocedural end points during the ablation procedure but may help to increase the predictive value of noninducible patients. Elimination of abnormal electrograms has been demonstrated to be beneficial in reducing recurrences and may be used in situations where not all VTs can be induced to prevent recurrences. 32 
Limitations
This meta-analysis is limited by the studies included in the analysis. All of the studies were observational studies, and 21, 25 did not report mortality events; therefore, they were not included in the overall analysis. CI indicates confidence interval. Figure 5 . Noninducible vs failed ablation and mortality. Three studies 21,25,26 did not report mortality events; therefore, they were not included in the overall analysis. CI indicates confidence interval. therefore they are susceptible to selection bias. There were significant differences in the patients included and the strategy used when performing VT ablations. Although the overall strategy was to target all inducible VTs, only 1 study indicated ablation of all clinically relevant VTs as a predetermined end point. 23 Table II in the Data Supplement indicates the specific protocols and catheters used in the analyzed studies.
Another important limitation is the definition of the clinical VT. The definition used in the selected studies is not uniform and is not based on the 12-lead ECG in all studies. Because 12-lead ECGs are not available for all patients, VT electrogram morphology from implantable cardioverter defibrillators can be used instead with similar accuracy and have been found to be helpful in identifying the clinical VT. 5 This definition was used by only one, but not all studies. 26 Although the stimulation protocol was not uniform, all studies included used stimulation from ≥2 ventricular sites with ≤3 extrastimuli. The details are indicated in Table II in the Data Supplement. Left ventricular stimulation was not uniformly used, yet the incremental benefit of left ventricular stimulation compared with stimulation from 2 right ventricular sites is rather small. 14 None of the included studies accounted for baseline differences when comparing the results of patients who remained inducible compared with those without inducible VT at the end of the ablation procedure. These differences may influence the short-term and long-term outcomes of the index VT ablation procedure. The ideal away to overcome the differences in baseline characteristics and follow-up would be to conduct a meta-analysis using individual patient data for timeto-event analysis. However, in the absence of such data, our analysis represents the best available evaluation of effects of noninducibility on outcomes after VT ablation. Unfortunately, because individual patient data were not available for analysis, we were not able to analyze data separately from a minority of patients in whom programmed stimulation was not performed at the conclusion of the ablation procedure. Furthermore, 1 study 27 included a minority of noninducible patients at the onset of the procedure, and a separate analysis excluding these patients could not be performed. Exclusion of this study, however, did not change the overall results of this analysis.
Conclusions
Noninducibility of any VT may be a preferred end point of VT ablation in patients with postinfarction VT. However, although this may be the most preferred end point, this should not compromise patient stability, which may be a concern in some patients with advanced disease. Whether noninducibility is an independent marker for improved long-term outcome remains to be determined. Additional studies are needed to evaluate the effect of different ablation strategies and end points to optimize the outcomes of patients undergoing VT ablation.
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